Merrimack Pharmaceuticals, Inc.
MACK · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$436 | -$240 | -$279 | -$391 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $48 | $48 | $48 | $47 |
| Change in WC | $226 | $30 | $167 | -$298 |
| Other Non-Cash | -$1,152 | -$133 | -$139 | -$26 |
| Operating Cash Flow | -$1,314 | -$295 | -$203 | -$668 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $225,000 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$5,932 | -$6,845 | -$8,811 |
| Inv. Sales/Matur. | $3,000 | $6,000 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $3,000 | -$9 |
| Investing Cash Flow | $228,000 | $68 | -$3,845 | -$8,811 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,485 | $133 | $0 | $209 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,485 | $133 | $0 | $209 |
| Financing Cash Flow | $1,485 | $133 | $0 | $209 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $228,171 | -$94 | -$4,048 | -$9,270 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,989 | $6,083 | $10,131 | $19,401 |
| End Cash | $234,160 | $5,989 | $6,083 | $10,131 |
| Free Cash Flow | -$1,314 | -$295 | -$203 | -$668 |